M33 Growth I L.P. → Oncology Institute, Inc. TOIIW

Stake: — Shares: —

Composite Decision Signal · PASS (LOW BASE-RATE EDGE) Conviction Score: 16/100

Passive Schedule 13G filer baseline
Elevated short days-to-cover (14.1 DTC)

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

2 transactions

0 buys · 2 sales · 0 awards/exercises

Issuer Cluster

8 13D/G filings on this issuer

7 other filings besides this one

Filer Track Record

3 filings by this filer

2 other filings in the data moat

Short Interest · settle 2026-07-31

DTC 14.13

7,801 shares short · -14.3% vs prior

Form 4 Insider Transactions · last 365d

Date	Insider	Role	Type	Shares	Price	Value
2026-04-16	Kaushal Mohit	director	Sale	38,433	$3.50	$135K
2026-04-14	Kaushal Mohit	director	Sale	57,286	$3.50	$201K

Other 13D/G Filings on Oncology Institute, Inc.

Filed	Form	Filer	Stake	Shares
2026-05-15	SCHEDULE 13D/A	M33 Growth I L.P.	—	5,002,656	view →
2024-01-02	SC	Havencrest Healthcare Partners, L.P.	—	—	view →
2022-09-26	SC	M33 Growth I L.P.	—	—	view →
2022-09-21	SC	Havencrest Healthcare Partners, L.P.	—	—	view →
2022-07-11	SC	Havencrest Healthcare Partners, L.P.	—	—	view →
2021-11-19	SC	Flynn James E	—	—	view →
2021-07-01	SC	Flynn James E	—	—	view →

Other Filings by M33 Growth I L.P.

Filed	Form	Issuer	Stake	Shares
2026-05-15	SCHEDULE 13D/A	Oncology Institute, Inc. TOIIW	—	5,002,656	view →
2022-09-26	SC	Oncology Institute, Inc. TOIIW	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →